These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 33850486)

  • 21. Clinical profiles of dementia with Lewy bodies with and without Alzheimer's disease-like hypometabolism.
    Chiba Y; Fujishiro H; Ota K; Kasanuki K; Arai H; Hirayasu Y; Sato K; Iseki E
    Int J Geriatr Psychiatry; 2015 Mar; 30(3):316-23. PubMed ID: 24839913
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical utility of FDG-PET for the clinical diagnosis in MCI.
    Arbizu J; Festari C; Altomare D; Walker Z; Bouwman F; Rivolta J; Orini S; Barthel H; Agosta F; Drzezga A; Nestor P; Boccardi M; Frisoni GB; Nobili F;
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1497-1508. PubMed ID: 29704037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. FDG-PET and CSF biomarker accuracy in prediction of conversion to different dementias in a large multicentre MCI cohort.
    Caminiti SP; Ballarini T; Sala A; Cerami C; Presotto L; Santangelo R; Fallanca F; Vanoli EG; Gianolli L; Iannaccone S; Magnani G; Perani D;
    Neuroimage Clin; 2018; 18():167-177. PubMed ID: 29387532
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combined evaluation of FDG-PET and MRI improves detection and differentiation of dementia.
    Dukart J; Mueller K; Horstmann A; Barthel H; Möller HE; Villringer A; Sabri O; Schroeter ML
    PLoS One; 2011 Mar; 6(3):e18111. PubMed ID: 21448435
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Severe Brain Metabolic Decreases Associated with REM Sleep Behavior Disorder in Dementia with Lewy Bodies.
    Iaccarino L; Marelli S; Iannaccone S; Magnani G; Ferini-Strambi L; Perani D
    J Alzheimers Dis; 2016 Apr; 52(3):989-97. PubMed ID: 27060952
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Imaging of amyloid plaques and cerebral glucose metabolism in semantic dementia and Alzheimer's disease.
    Drzezga A; Grimmer T; Henriksen G; Stangier I; Perneczky R; Diehl-Schmid J; Mathis CA; Klunk WE; Price J; DeKosky S; Wester HJ; Schwaiger M; Kurz A
    Neuroimage; 2008 Jan; 39(2):619-33. PubMed ID: 17962045
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Metabolic imaging patterns in posterior cortical atrophy and Lewy body dementia.
    Gupta V; Verma R; Ranjan R; Belho ES; Seniaray N; Dinand V; Malik D; Mahajan H
    Nucl Med Commun; 2019 Dec; 40(12):1275-1282. PubMed ID: 31633646
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of early-phase [
    Daerr S; Brendel M; Zach C; Mille E; Schilling D; Zacherl MJ; Bürger K; Danek A; Pogarell O; Schildan A; Patt M; Barthel H; Sabri O; Bartenstein P; Rominger A
    Neuroimage Clin; 2017; 14():77-86. PubMed ID: 28138429
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lewy Body Disease is a Contributor to Logopenic Progressive Aphasia Phenotype.
    Buciuc M; Whitwell JL; Kasanuki K; Graff-Radford J; Machulda MM; Duffy JR; Strand EA; Lowe VJ; Graff-Radford NR; Rush BK; Franczak MB; Flanagan ME; Baker MC; Rademakers R; Ross OA; Ghetti BF; Parisi JE; Raghunathan A; Reichard RR; Bigio EH; Dickson DW; Josephs KA
    Ann Neurol; 2021 Mar; 89(3):520-533. PubMed ID: 33274526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Based on the Network Degeneration Hypothesis: Separating Individual Patients with Different Neurodegenerative Syndromes in a Preliminary Hybrid PET/MR Study.
    Tahmasian M; Shao J; Meng C; Grimmer T; Diehl-Schmid J; Yousefi BH; Förster S; Riedl V; Drzezga A; Sorg C
    J Nucl Med; 2016 Mar; 57(3):410-5. PubMed ID: 26585059
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of FDG-PET and IMP-SPECT in patients with dementia with Lewy bodies.
    Ishii K; Hosaka K; Mori T; Mori E
    Ann Nucl Med; 2004 Jul; 18(5):447-51. PubMed ID: 15462408
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Brain fluorodeoxyglucose (FDG) PET in dementia.
    Kato T; Inui Y; Nakamura A; Ito K
    Ageing Res Rev; 2016 Sep; 30():73-84. PubMed ID: 26876244
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of regional brain volume and glucose metabolism between patients with mild dementia with lewy bodies and those with mild Alzheimer's disease.
    Ishii K; Soma T; Kono AK; Sofue K; Miyamoto N; Yoshikawa T; Mori E; Murase K
    J Nucl Med; 2007 May; 48(5):704-11. PubMed ID: 17475957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cerebral Hypoperfusion and Hypometabolism Detected by Arterial Spin Labeling MRI and FDG-PET in Early-Onset Alzheimer's Disease.
    Verclytte S; Lopes R; Lenfant P; Rollin A; Semah F; Leclerc X; Pasquier F; Delmaire C
    J Neuroimaging; 2016; 26(2):207-12. PubMed ID: 26031943
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Voxel-based comparison of regional cerebral glucose metabolism between PSP and corticobasal degeneration.
    Hosaka K; Ishii K; Sakamoto S; Mori T; Sasaki M; Hirono N; Mori E
    J Neurol Sci; 2002 Jul; 199(1-2):67-71. PubMed ID: 12084445
    [TBL] [Abstract][Full Text] [Related]  

  • 36. 11C-PIB PET imaging in Alzheimer disease and frontotemporal lobar degeneration.
    Rabinovici GD; Furst AJ; O'Neil JP; Racine CA; Mormino EC; Baker SL; Chetty S; Patel P; Pagliaro TA; Klunk WE; Mathis CA; Rosen HJ; Miller BL; Jagust WJ
    Neurology; 2007 Apr; 68(15):1205-12. PubMed ID: 17420404
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Metabolic connectivity for differential diagnosis of dementing disorders.
    Titov D; Diehl-Schmid J; Shi K; Perneczky R; Zou N; Grimmer T; Li J; Drzezga A; Yakushev I
    J Cereb Blood Flow Metab; 2017 Jan; 37(1):252-262. PubMed ID: 26721391
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical utility of FDG-PET for the differential diagnosis among the main forms of dementia.
    Nestor PJ; Altomare D; Festari C; Drzezga A; Rivolta J; Walker Z; Bouwman F; Orini S; Law I; Agosta F; Arbizu J; Boccardi M; Nobili F; Frisoni GB;
    Eur J Nucl Med Mol Imaging; 2018 Jul; 45(9):1509-1525. PubMed ID: 29736698
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Atrophy, hypometabolism and clinical trajectories in patients with amyloid-negative Alzheimer's disease.
    Chételat G; Ossenkoppele R; Villemagne VL; Perrotin A; Landeau B; Mézenge F; Jagust WJ; Dore V; Miller BL; Egret S; Seeley WW; van der Flier WM; La Joie R; Ames D; van Berckel BN; Scheltens P; Barkhof F; Rowe CC; Masters CL; de La Sayette V; Bouwman F; Rabinovici GD
    Brain; 2016 Sep; 139(Pt 9):2528-39. PubMed ID: 27357349
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical Use of Integrated Positron Emission Tomography-Magnetic Resonance Imaging for Dementia Patients.
    Shepherd TM; Nayak GK
    Top Magn Reson Imaging; 2019 Dec; 28(6):299-310. PubMed ID: 31794502
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.